Avere Therapeutics Secures $500 Million Private Placement—Fully Funds Development Through 2029 in NextCure Merger
Market Chameleon (Mon, 10-Aug 7:29 AM)
NextCure Shareholders Face Just 1.21% Ownership in New Avere Merger—Is This a Fair Deal?
Market Chameleon (Mon, 27-Jul 11:24 AM)
